General Considerations

•ADC and LSA are the most common large intestinal tumors in cats

•other large intestinal tumors include MCT, HSA, and neuroendocrine carcinoma

•intestinal HSA metastatic to regional lymph nodes and carcinomatosis has been reported

•ileocolic junction most common site for large intestinal tumors


Clinical Signs

•hematochezia, vomiting, and weight loss


Diagnosis


Physical Examination

•cachexia is common

•abdominal mass is frequently palpable via either abdomen and rectal palpation

•other findings include dehydration and abdominal pain


Ultrasonography

•circumferential transmural thickening with loss of normal intestinal layering reported in 5 cats with intestinal ADC


Endoscopy

•endoscopy is recommended prior to definitive treatment

•biopsy samples should be interpreted histologically as cytologic misdiagnosis is common with intestinal ADC being misdiagnosed as either septic inflammation or LSA

•biopsy samples are often small and superficial resulting in false-negative diagnosis if lesion is either submucosal or associated with surface ulceration and necrosis


Exploratory Celiotomy

•definitive diagnosis with exploratory celiotomy and biopsy

•feline large intestinal ADC more commonly associated with mucosal ulceration and bowel thickening than annular stenosis

•leiomyoma and sarcoma are usually large solitary masses growing through the intestinal serosa


Treatment


Surgery

•debilitation and hypoproteinemia may complicate treatment

•exploratory celiotomy with resection and end-to-end anastomosis with 4-8 cm margins and serosal patching of anastomosis

•mesenteric and regional lymph nodes should be assessed ± aspirated


Chemotherapy

•multiagent protocols recommended for LSA as either adjuvant therapy or sole treatment for diffuse disease

•chemotherapy is also recommended for cats with intestinal plasmacytoma and MCT

•no effective chemotherapy for ADC


Prognosis

•MST for cats with colonic tumors is significantly better with:

•surgical resection compared to conservative management (198 days v 22 days)

•MCT compared to LSA (199 days v 97 days)

•no metastasis in cats with ADC (49 days v 259 days)

•however, some cats with metastatic disease had prolonged survival time

SURGICAL ONCOLOGY

SOCIETY

RESEARCH

EDUCATION

LINKS

EMPLOYMENT

 IMAGE LIBRARYImages.html
● HistoryHistory.html
● What is a Surgical OncologistSurgical_Oncology_1.html
● Find a Surgical OncologistSurgical_Oncology_2.html
● Aims and ObjectivesAims.html
● MembershipMembership.html
● CommitteesCommittees.html
● NewsletterNewsletter.html
● Constitution and BylawsConstitution.html
● Research TrialsResearch_Trials.html
● Publications by MembersPublications.html
● Research OpportunitiesResearch_Opportunities.html
● Cancer InformationCancer_Information_1.html
● Conferences and MeetingsConferences.html
● Radiation FacilitiesRadiation_Facilities.html
● CE OpportunitiesCE_Opportunities.html
● Cancer InformationCancer_Information_2.html
● Current OpportunitiesEmployment_Opportunities.html
● Fellowship Training GuidelinesFellowship_Guidelines.html

LARGE INTESTINAL TUMORS

● Surgical Oncology JournalsJournals.html
● Surgical Oncology SocietiesSocieties.html
● Veterinary Surgery CollegesColleges.html